Risk of Coccidioidomycosis in Patients Receiving Anti-TNF and Other Biologic Agents for an Inflammatory Arthritis

Completed

Conditions studied: Coccidioidomycosis, Rheumatoid Arthritis

In brief

The goal of the project is to study the risk of coccidioidomycosis (valley fever) in patients receiving anti-TNF and other biologic agents for inflammatory arthritis in Tucson, Arizona.

Key facts

Study ID

NCT00796809

Run by

University of Arizona

People needed

598

Starts

2007-10-01

Expected to finish

2008-10-01

Last updated by the study team

2015-12-14

Who can join

Age: any. Sex: any. Healthy volunteers: accepted.

You may qualify if…

• All active patients with an inflammatory arthritis seen at the University of Arizona from January 2000

You may not qualify if…

• None

Where it is running

• University of Arizona - Arizona Arthritis Center — Tucson, Arizona, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.